AB0 blood group and prognosis in patients with pancreatic cancer

Although blood group 0 is associated with a reduced risk of pancreatic cancer, little is known about the role of AB0 blood group antigens in disease progression. We assessed the prognostic relevance of AB0 blood status in a large cohort of patients with resected pancreatic cancer.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Rahbari, Nuh Nabi (VerfasserIn) , Bork, Ulrich (VerfasserIn) , Hinz, Ulf (VerfasserIn) , Leo, Albrecht (VerfasserIn) , Kirchberg, Johanna (VerfasserIn) , Koch, Moritz (VerfasserIn) , Büchler, Markus W. (VerfasserIn) , Weitz, Jürgen (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 28 July 2012
In: BMC cancer
Year: 2012, Jahrgang: 12, Heft: 1
ISSN:1471-2407
DOI:10.1186/1471-2407-12-319
Online-Zugang:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/1471-2407-12-319
Verlag, kostenfrei, Volltext: https://doi.org/10.1186/1471-2407-12-319
Volltext
Verfasserangaben:Nuh N. Rahbari, Ulrich Bork, Ulf Hinz, Albrecht Leo, Johanna Kirchberg, Moritz Koch, Markus W. Büchler and Jürgen Weitz
Beschreibung
Zusammenfassung:Although blood group 0 is associated with a reduced risk of pancreatic cancer, little is known about the role of AB0 blood group antigens in disease progression. We assessed the prognostic relevance of AB0 blood status in a large cohort of patients with resected pancreatic cancer.
Beschreibung:Gesehen am 26.11.2018
Beschreibung:Online Resource
ISSN:1471-2407
DOI:10.1186/1471-2407-12-319